about
Progressive pathology is functionally linked to the domains of language and emotion: meta-analysis of brain structure changes in schizophrenia patientsBrain structure anomalies in autism spectrum disorder--a meta-analysis of VBM studies using anatomic likelihood estimationNeural networks related to dysfunctional face processing in autism spectrum disorder[Correlations between risk gene variants for schizophrenia and brain structure anomalies].Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2.[Genetic and brain structure anomalies in autism spectrum disorders. Towards an understanding of the aetiopathogenesis?].White matter microstructural changes in adolescent anorexia nervosa including an exploratory longitudinal study.A Neuregulin-1 schizophrenia susceptibility variant causes perihippocampal fiber tract anomalies in healthy young subjects.The role of neurotrophic factors in autism.Searching for behavior relating to grey matter volume in a-priori defined right dorsal premotor regions: Lessons learned.Neuroanatomic changes and their association with cognitive decline in mild cognitive impairment: a meta-analysisChanges in grey matter development in autism spectrum disorder.The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2.Genetic variation in the G72 gene is associated with increased frontotemporal fiber tract integrity.Drug interaction can lead to undetectable serum concentrations of quetiapine in the presence of carbamazepine.Psychiatric symptoms in a patient with Wolfram syndrome caused by a combination of thalamic deficit and endocrinological pathologies.Male-specific deficits in natural reward learning in a mouse model of neurodevelopmental disorders.Neural correlates of formal thought disorder: An activation likelihood estimation meta-analysis.Hyperactivity and male-specific sleep deficits in the 16p11.2 deletion mouse model of autism.Are morphological changes necessary to mediate the therapeutic effects of electroconvulsive therapy?Lack of meta-analytic evidence for an impact of COMT Val158Met genotype on brain activation during working memory tasks.The impact of a Dysbindin schizophrenia susceptibility variant on fiber tract integrity in healthy individuals: a TBSS-based diffusion tensor imaging study.Meta-analytic evidence for altered mesolimbic responses to reward in schizophrenia.[Meta-analyses in clinical brain research].Differential Resting-State Connectivity Patterns of the Right Anterior and Posterior Dorsolateral Prefrontal Cortices (DLPFC) in Schizophrenia.Linking spatial gene expression patterns to sex-specific brain structural changes on a mouse model of 16p11.2 hemideletion.Neural networks of aggression: ALE meta-analyses on trait and elicited aggressionAldehyde dehydrogenase 2 in sporadic Parkinson's diseaseNerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia PatientsAccessibility, standards and challenges of electroconvulsive therapy in Western industrialized countries: a German exampleUsing coordinate-based meta-analyses to explore structural imaging geneticsElectroconvulsive therapy induced gray matter increase is not necessarily correlated with clinical data in depressed patients
P50
Q24174832-0B34E4AB-8FA5-4337-96A6-66F6CC9EC54AQ26722178-6334F0C2-A074-4C5A-B8BA-FC0590E0E704Q28603116-BB126077-C915-465E-8EF4-48319DF62A5FQ33372366-C97E3A01-B5DD-4F52-ABAA-CF570E88306EQ33387162-4D5D2DA4-A56D-4630-BC24-3F6606CDBD2DQ33560765-8AB6A9F8-96D5-4E2D-8D57-364BF7BB29F4Q36871223-123628FB-7DC9-4DC4-A05C-C34782A43D59Q37668038-7F8DD592-9B77-4BFC-B422-B849D9949F17Q37799527-1EA930B5-B2B7-4498-9E82-70E37B5A30C9Q38677930-42A80502-74C3-4AF9-9474-665326893BEBQ38989198-5910BC6B-1016-4A88-BF62-BD0E27BD3338Q41523977-8030A1E8-9122-4A58-B7F4-50ED4175FBC0Q41870574-878FC697-6FF0-4098-8C62-34267ED15D41Q42672368-37A5EE09-5CE9-40BE-9F92-957F8506E771Q45995674-366711C3-621B-4D3B-B574-B4D774A20547Q46193820-20740D2C-3D8C-4312-9C9C-544A4939B000Q47241090-C567D027-9386-4E2F-BCA7-78E6CA28054EQ47786532-90C63BAA-0FB0-4BB0-AC13-BF121B44D58DQ47807134-CF9A74C9-3F95-4A62-86B0-778901404CE0Q48076139-35982D34-8CF7-433C-949D-36FF69FBAA9EQ48236429-25A7F15B-FEFA-43A6-A0A7-41D3D297FA79Q48825356-D6268A47-C29D-41CA-8738-54221FEFBE2BQ52639022-866FC618-20D7-430E-9E0B-15DA396E16C6Q53315241-4EDEC8D7-E1F8-4C63-8964-7189EDA71EA5Q55037247-3EAC64E6-0C47-412E-B620-5362D66B2DC6Q55122086-9CD32A8F-9784-4DD9-9157-DE3224EDC791Q57021327-29F22019-C8C6-4D2E-9ACE-8865A94C380AQ59151338-C0A9C77B-D821-433C-BC2B-FEFAACBA7AFCQ64085430-C81168BA-D3D1-4898-8C7B-CF7B2C4531E6Q83626285-4C62DB7C-6131-445B-8C54-4D5DADFBDAA3Q88581171-8DB6EE8B-B306-4707-AD3D-3B6D4A762A6CQ90567433-29AA623F-5CF7-477D-AD9C-9D6AE1A55BC3
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-2616-6503
@en
name
Thomas Nickl-Jockschat
@ast
Thomas Nickl-Jockschat
@en
Thomas Nickl-Jockschat
@es
Thomas Nickl-Jockschat
@nl
type
label
Thomas Nickl-Jockschat
@ast
Thomas Nickl-Jockschat
@en
Thomas Nickl-Jockschat
@es
Thomas Nickl-Jockschat
@nl
prefLabel
Thomas Nickl-Jockschat
@ast
Thomas Nickl-Jockschat
@en
Thomas Nickl-Jockschat
@es
Thomas Nickl-Jockschat
@nl
P106
P1153
16200290600
P31
P496
0000-0003-2616-6503